Samsung Biologics Co.,Ltd. (KRX:207940)
1,641,000
-39,000 (-2.32%)
At close: Dec 5, 2025
Samsung Biologics Market Cap
Samsung Biologics has a market cap or net worth of 75.96 trillion as of December 5, 2025. Its market cap has increased by 0.97% in one year.
Market Cap
75.96T
Enterprise Value
75.23T
Revenue
5.50T
Ranking
n/a
PE Ratio
47.60
Stock Price
1,641,000.00
Market Cap Chart
Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 75.96T, an increase of 697.29%. That is a compound annual growth rate of 25.71%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8,755.13B |
| LigaChem Biosciences | 6,753.15B |
| Peptron | 6,645.44B |
| HLB Co., Ltd. | 6,460.44B |